Six AI updates in GI for 2021

Artificial intelligence has a growing presence in gastroenterology. From colonoscopy procedures to imaging techniques, here is a link to six AI updates in GI so far in 2021:

Original article From Becker’s ASC

AI in GI: 6 updates in 2021

Artificial intelligence has a growing presence in gastroenterology. From colonoscopy procedures to imaging techniques, here are six AI updates in GI so far in 2021:

1. The FDA granted de novo clearance for Medtronic’s first AI system for colonoscopies. The endoscopy module, GI Genius, uses AI to identify colorectal polyps, according to an April 12 news release.

2. Pristine Surgical and NexOptic have agreed to combine their technologies for a single-use endoscopic visualization platform. Pristine Surgical’s single-use endoscopes will use NexOptic’s AI imaging technology, All Light Intelligent Imaging Solutions, according to an April 7 news release.

3. A team at Washington University in St. Louis developed an imaging technique for rectal tissues to assess risk management of CRC. Biomedical professor Quing Zhu, PhD, and her team created the imaging technique, acoustic resolution photoacoustic microscopy coregistered with ultrasound, and paired it with AI.

4. GI-focused software companies Iterative Scopes and Provation partnered to link Provation’s GI documentation software with Iterative Scopes’ inflammatory bowel disease data and AI insights, according to a March 17 news release.

5, A partnership reached between Iterative Scopes and Eli Lilly Feb. 18 will explore how AI can improve understanding of IBD pathophysiology and target identification. Iterative Scopes closed a $5.2 million seed round in January 2020.

6. Chattanooga, Tenn.-based Erlanger Health System began a clinical trial to test an AI device used to increase polyp detection during colonoscopy, thechattanoogan.com reported Feb. 8.

CMS Will Eliminate Inpatient-Only Procedure List by 2024

This year, ASCs can perform and be paid for hundreds of additional procedures.

JOINT SUPPLEMENT CMS will now pay for total hip replacements performed at ASCs.

CMS’s Outpatient Prospective Payment System and Ambulatory Surgical Center final rule, which took effect on January 1, further blurs the lines between inpatient and outpatient surgical care, as well as between ASCs and HOPDs within the outpatient sphere.

The big news is the gradual elimination of the inpatient-only procedure list. This year, CMS has removed a total of 298 mostly musculoskeletal procedures from that list, and now will pay for them in HOPD settings when clinically appropriate. By 2024, the remaining 1,400 or so procedures on the inpatient-only list will be removed. Read more